Navigation Links
Biotech Company Ansaris Selects Surety for Integrity and Authenticity Protection of Its Lab Informatics Data
Date:1/28/2010

AbsoluteProof eases process scientists follow to "sign" and "witness" volumes of research records.

Reston, VA (PRWEB) January 28, 2010 -- Surety, LLC, the leading provider of data integrity protection solutions, today announced that Ansaris, a drug discovery and development company, has selected Surety's AbsoluteProof® trusted, digital timestamping service for integration into its lab informatics systems to protect the data's integrity and authenticity. With AbsoluteProof, information stored within Ansaris' electronic lab environment will be properly "sealed," ensuring its research records are in legally acceptable evidentiary form should the company's intellectual property rights and ownership to a particular invention ever be questioned or challenged.

Ansaris is a drug-discovery company focused on solving small-molecule challenges by utilizing its proprietary technology platform. The company integrates fragment-based drug design, protein modelling and medicinal chemistry and biology expertise to identify novel therapeutics. Critical to the drug-discovery process is the ability to prove "time of invention" in order to protect intellectual property that is generated.

"Prior to implementing AbsoluteProof, we required scientists to save their experiments to DVD, and then have them physically signed, countersigned and witnessed," said Joan Lau, President and CEO, Ansaris. "This process was labor-intensive and time consuming. Considering that only 20 percent of our industry has a purely electronic solution for archival, our challenge was to design and implement a lab informatics solution that could satisfy the requirements of proving inventorship."

Using its electronic lab notebooks (ELNs) as a starting point for its implementation of an electronic archival process, Ansaris scientists seamlessly export their experiments to the company's network, upon which AbsoluteProof then time stamps, or 'seals,' the document, recording the exact time, date and format in which it existed. The document is then conveniently accessible to additional scientists, who can then view the sealed electronic record. This process assures Ansaris and its scientists that their work is authentic and safe from potential tampering or intellectual property theft. What once took 15 scientists nearly 10 hours per month executing the process, Ansaris' electronic lab environment with AbsoluteProof integrated into it has since reduced the time to less than one hour per month. This translates into savings of hundreds of thousands of dollars per year.

"With AbsoluteProof, Ansaris and its collaboration partners can be confident in the fact that their scientific intellectual property data can and will remain secure with minimal time commitment from its scientists," said Bob Flinton, VP of Marketing and Product Management for Surety. "Being integrated into the Ansaris' ELN solution to improve the invention process, Surety's AbsoluteProof has helped the company reduce the amount of time and resources spent on managing electronic scientific records."

Legally Defensible Proof of Authenticity
As a Surety customer, Ansaris qualifies for Surety's Legal Defensibility Guarantee, delivering to Ansaris the confidence that its critical electronic records, files and other digital content will withstand the most vigorous legal scrutiny. Under the guarantee, Ansaris will receive access, if needed, to sworn affidavits and expert witness testimony to the quality of the underlying technology, confirming that the Seals provided by the AbsoluteProof service are authentic and have not been compromised, as well as a money-back guarantee should a federal, state or local court in any jurisdiction render a final and non-appealable decision that Surety has not been able to satisfy its claims.

For complete details about Ansaris' successful implementation of AbsoluteProof, visit www.surety.com/resources/success-stories. For more information about Surety or AbsoluteProof, visit www.surety.com.

About Surety, LLC
Founded in 1994 by leading Bellcore Scientists, Surety is recognized as a premiere third-party trusted time-stamp authority. With millions of electronic records and files worldwide protected under its authenticity seal, the company's flagship service offering AbsoluteProof® enables organizations to meet the legal, fiduciary and regulatory responsibilities associated with creating, managing and archiving electronic data by providing legally defensible evidence of integrity and authenticity. AbsoluteProof ensures against content or record tampering by providing a "digital wax seal" for all types of electronically stored content. The company's client base is made up of pharmaceutical and bio-technology companies, legal and financial services firms, research and development laboratories, healthcare organizations, managed services providers and copyright protection agencies that are ensuring record integrity with AbsoluteProof. For more information, visit www.surety.com.

About Ansaris
Ansaris is a division of Locus Pharmaceuticals, Inc., a privately held drug discovery and development company based in Blue Bell, PA, creating novel therapeutics using its patented drug-design technology. Ansaris has entered into several drug discovery collaboration projects with pharmaceutical partners, and has built a pipeline of early drug-development assets for cancer and inflammatory indications using its computational and medicinal chemistry resources and technology.

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3534524.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Glycos Biotechnologies Appoints Chief Executive Officer
2. Resverlogix Presenting at Biotech Showcase
3. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
4. The Massachusetts Biotechnology Council Selects Social Media Marketing Agency 451 Marketing To Develop A Social Media Strategy For 2010
5. For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
6. For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
7. CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
8. Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement
9. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
10. Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Companys First Annual 2010 Micro Cap Conference
11. YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):